Association between heparin dose and 6-weeks mortality in patients with covid-19

ConclusionsOur results reported a significant positive effect of intermediate and therapeutic doses of heparin, compared with a prophylactic dose, on 6-week survival for hospitalized COVID-19 patients.

Source: Mediterranean Journal of Hematology and Infectious Diseases - April 28, 2022 Category: Hematology Authors: Claire Coutureau, Philippe Nguyen, Maxime Hentzien, Peter Joe Noujaim, Sarah Zerbib, Damien Jolly, Lukshe Kanagaratnam Source Type: research